{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:06:30Z","timestamp":1784106390559,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>In this randomized-controlled pilot study, the feasibility and safety of tacrolimus monotherapy in immunologically low-risk kidney transplant recipients was evaluated [NTR4824, <jats:ext-link>www.trialregister.nl<\/jats:ext-link>]. Low immunological risk was defined as maximal 3 HLA mismatches and the absence of panel reactive antibodies. Six months after transplantation, recipients were randomized if eGFR &amp;gt;30\u00a0ml\/min, proteinuria &amp;lt;50\u00a0mg protein\/mmol creatinine, no biopsy-proven rejection after 3\u00a0months, and no lymphocyte depleting therapy given. Recipients were randomized to tacrolimus\/mycophenolate mofetil (TAC\/MMF) or to taper and discontinue MMF at month 9 (TACmono). 79 of the 121 recipients were randomized to either TACmono (<jats:italic>n<\/jats:italic> = 38) or TAC\/MMF (<jats:italic>n<\/jats:italic> = 41). Mean recipient age was 59\u00a0years and 59% received a living donor transplant. The median follow-up was 62\u00a0months. After randomization, 3 TACmono and 4 TAC\/MMF recipients experienced a biopsy-proven rejection. At 5\u00a0years follow-up, patient survival was 84% in TACmono versus 76% in TAC\/MMF with death-censored graft survival of 97% for both groups and no differences in eGFR and proteinuria. Eleven TACmono recipients had an infectious episode versus 22 TAC\/MMF recipients (<jats:italic>p<\/jats:italic> &amp;lt; 0.03). Donor-specific anti-HLA antibodies were not detected during follow-up in both groups. Tacrolimus monotherapy in selected immunologically low-risk kidney transplant recipients appears safe and reduces the number of infections.<\/jats:p>","DOI":"10.3389\/ti.2022.10839","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T04:11:22Z","timestamp":1666584682000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study"],"prefix":"10.3389","volume":"35","author":[{"given":"Annelies E.","family":"de Weerd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab Al","family":"Fatly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieken","family":"Boer-Verschragen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Kal-van Gestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave L.","family":"Roelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Dieterich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel G. H.","family":"Betjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajt.13195","article-title":"OPTN\/SRTR 2013 Annual Data Report: Kidney","volume":"15","author":"Matas","year":"2015","journal-title":"Am J Transpl"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 Annual Data Report: Kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transpl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0250796","DOI":"10.1371\/journal.pone.0250796","article-title":"Risk Factors for Unfavorable Outcome and Impact of Early post-transplant Infection in Solid Organ Recipients with COVID-19: A Prospective Multicenter Cohort Study","volume":"16","author":"Salto-Alejandre","year":"2021","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.lanepe.2021.100178","article-title":"Humoral and Cellular Immunity to SARS-CoV-2 Vaccination in Renal Transplant versus Dialysis Patients: A Prospective, Multicenter Observational Study Using mRNA-1273 or BNT162b2 mRNA Vaccine","volume":"9","author":"Stumpf","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced Humoral Response to mRNA SARS-CoV-2 BNT162b2 Vaccine in Kidney Transplant Recipients without Prior Exposure to the Virus","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transpl"},{"key":"B6","doi-asserted-by":"publisher","first-page":"656846","DOI":"10.3389\/fimmu.2021.656846","article-title":"Expression of Senescence Marker TIGIT Identifies Polyfunctional Donor-Reactive CD4+ T Cells Preferentially Lost after Kidney Transplantation","volume":"12","author":"van der List","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1681\/ASN.2005030312","article-title":"Predictive Factors of Acute Rejection after Early Cyclosporine Withdrawal in Renal Transplant Recipients Who Receive Mycophenolate Mofetil: Results from a Prospective, Randomized Trial","volume":"16","author":"Hazzan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/TP.0b013e31822ca7ca","article-title":"Kidney Transplantation with Minimized Maintenance: Alemtuzumab Induction with Tacrolimus Monotherapy-Aan Open Label, Randomized Trial","volume":"92","author":"Chan","year":"2011","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1111\/ajt.16563","article-title":"Preformed T Cell Alloimmunity and HLA Eplet Mismatch to Guide Immunosuppression Minimization with Tacrolimus Monotherapy in Kidney Transplantation: Results of the CELLIMIN Trial","volume":"21","author":"Bestard","year":"2021","journal-title":"Am J Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/TP.0b013e31825c1d6c","article-title":"Tacrolimus-based, Steroid-free Regimens in Renal Transplantation: 3-year Follow-Up of the ATLAS Trial","volume":"94","author":"Kramer","year":"2012","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/tan.12860","article-title":"How Can We Reduce Costs of Solid-phase Multiplex-Bead Assays Used to Determine Anti-HLA Antibodies?","volume":"88","author":"Kamburova","year":"2016","journal-title":"HLA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin Inhibitor Nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1111\/ajt.13946","article-title":"Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients","volume":"16","author":"Dugast","year":"2016","journal-title":"Am J Transpl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the Causes of Kidney Transplant Failure: the Dominant Role of Antibody-Mediated Rejection and Nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transpl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0196552","DOI":"10.1371\/journal.pone.0196552","article-title":"Tacrolimus Intra-patient Variability Is Not Associated with Chronic Active Antibody Mediated Rejection","volume":"13","author":"Sablik","year":"2018","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"675301","DOI":"10.1155\/2014\/675301","article-title":"Attitudes to Medication after Kidney Transplantation and Their Association with Medication Adherence and Graft Survival: a 2-year Follow-Up Study","volume":"2014","author":"Tielen","year":"2014","journal-title":"J Transpl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transpl"},{"key":"B19","doi-asserted-by":"publisher","first-page":"842419","DOI":"10.3389\/fmed.2022.842419","article-title":"Causes of Kidney Graft Failure in a Cohort of Recipients with a Very Long-Time Follow-Up after Transplantation","volume":"9","author":"Betjes","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/tri.13726","article-title":"Association of Graft Survival with Tacrolimus Exposure and Late Intra-patient Tacrolimus Variability in Pediatric and Young Adult Renal Transplant Recipients-An International CTS Registry Analysis","volume":"33","author":"Gold","year":"2020","journal-title":"Transpl Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1111\/ajt.15346","article-title":"Late Intra-patient Tacrolimus Trough Level Variability as a Major Problem in Kidney Transplantation: A Collaborative Transplant Study Report","volume":"19","author":"Susal","year":"2019","journal-title":"Am J Transpl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-6143.2008.02492.x","article-title":"Two Hundred Living Donor Kidney Transplantations under Alemtuzumab Induction and Tacrolimus Monotherapy: 3-year Follow-Up","volume":"9","author":"Tan","year":"2009","journal-title":"Am J Transpl"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/tri.13993","article-title":"Is Simplification of Immunosuppressive Medication a Way to Promote Medication Adherence of Kidney Transplant Recipients? Findings from a Randomized Controlled Trial","volume":"34","author":"van Zanten","year":"2021","journal-title":"Transpl Int"},{"key":"B24","doi-asserted-by":"publisher","first-page":"933954","DOI":"10.3389\/fneph.2022.933954","article-title":"The Burden of Gastrointestinal Complaints in Kidney Transplant Recipients Using Tacrolimus With and Without Mycophenolate Mofetil: A Randomized Controlled Study","volume":"2","author":"Fatly","year":"2022","journal-title":"Front Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.ekir.2022.04.002","article-title":"COVID-19 Vaccination Response in Kidney Transplant Recipients with and without Mycophenolate Mofetil: Follow-Up of a Randomized Controlled Trial","volume":"7","author":"Al Fatly","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40620-016-0354-x","article-title":"Profiling Risk for Acute Rejection in Kidney Transplantation: Recipient Age Is a Robust Risk Factor","volume":"30","author":"Rana","year":"2017","journal-title":"J Nephrol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/00007890-200003150-00037","article-title":"Increased Immunosuppressive Vulnerability in Elderly Renal Transplant Recipients","volume":"69","author":"Meier-Kriesche","year":"2000","journal-title":"Transplantation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E224","DOI":"10.3390\/toxins12040224","article-title":"Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses","volume":"12","author":"Betjes","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrneph.2012.242","article-title":"Kidney Transplantation and the Ageing Immune System","volume":"8","author":"McKay","year":"2012","journal-title":"Nat Rev Nephrol"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2022.10839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T04:11:25Z","timestamp":1666584685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2022.10839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":29,"alternative-id":["10.3389\/ti.2022.10839"],"URL":"https:\/\/doi.org\/10.3389\/ti.2022.10839","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"10839"}}